NTRR: Mexico Supreme Court Ruling Could Propel Huge Expansion of North American Cannabis Market

As Neutra Corp. (OTCQB: NTRR) continues to field interest in its horticultural technologies from businesses in the U.S. cannabis industry, a new court ruling in Mexico could potentially prompt another major expansion in regulated cannabis growing across the continent.

This month, Mexico’s Supreme Court declared the prohibition of cannabis for consumption to be unconstitutional. The ruling only applied to the specific case before the Court, but it sets an important new legal precedent that has led to a national debate over the country’s existing laws. Many observers believe that it could be the first step toward a new, regulated cannabis market in Mexico.

“There are now regulated cannabis marketplaces in both the United States and Canada, and it is hardly a stretch to say that Mexico is likely to follow suit,” said NTRR CEO Chris Brown. “Mexico includes many regions ideal for cannabis cultivation, and when the laws begin to change, we want to be part of the industry vanguard offering new solutions to growers there.”

Alongside its joint venture partner, Surface to Air Solutions (S2O2), NTRR is offering cannabis growers and other businesses new technologies designed to reduce or eliminate the industry’s reliance upon pesticides to produce healthy crops. NTRR completed a successful case study on some of its horticultural products earlier this year in Colorado. The products are already in use in growing facilities in the U.S. and Canada. NTRR is continually meeting with manufacturers to add the latest and greatest innovations to its lineup.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. (OTCBB: EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151118006162/en/